SHANNON MILLER: Open Payments
NPI 1063850766 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 47 payments from 15 companies in 2025. Trend: 2023 $364 · 2024 $467 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $152 |
| AstraZeneca Pharmaceuticals LP | 8 | $143 |
| Lilly USA, LLC | 7 | $110 |
| PFIZER INC. | 5 | $87 |
| Dexcom, Inc. | 2 | $52 |
| Novo Nordisk Inc | 3 | $48 |
| GlaxoSmithKline, LLC. | 3 | $43 |
| Astellas Pharma US Inc | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $33 |
| Abbott Laboratories | 2 | $30 |
Products named: QULIPTA, FARXIGA, MOUNJARO, PREVNAR 20, AIRSUPRA, Dexcom G6 Transmitter, Veozah, Kerendia.
Industry payments across OK — which companies pay providers there.
